leisure time -WSS

leisure time

author：focus 2025-09-05 11:26:08 - browse：647

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

knowledge

WSS

Does good food count as health care? Study aims to find out

Childhood cancer progress stalls for Black, Hispanic kids: Report

FDA advisers back CAR

John Green on his newest strategy for fighting tuberculosis

Does good food count as health care? Study aims to find out

Morphosys mixed study results for blood cancer drug

Wikipedia

leisure time

entertainment

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HHS secretary Becerra pressed on Change HealthCare cyberattack

Sports medicine is finally prioritizing gender equality

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Drug repurposing or repositioning? The language matters

NYU radiologists take on the challenge of expensive MRI machines

ChatGPT in medicine: STAT answers readers' burning questions

Pushing for an NIH office for post

entertainment

CRISPR pioneers react to Casgevy, first gene

Why depression after traumatic brain injury is distinct

Readout Newsletter: CAR

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

HHS secretary Becerra pressed on Change HealthCare cyberattack

As AI in medicine takes off, can 'human in the loop' prevent harm?

focus

knowledge

entertainment

entertainment